Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Chamoun · SciRah

Researcher profile · Semantic Scholar

K. Chamoun

Share profile

K. Chamoun — researcher profile on SciRah

h-index: 11
Works: 51
Citations: 491

Most-cited papers

Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience
K. Chamoun, H. Kantarjian, Rami Atallah, G. Nogueras-González +13 more
2019Journal of Hematology & Oncology141 citations Open access
Semantic Scholar
Ibrutinib monotherapy in relapsed/refractory CNS lymphoma: A retrospective case series
K. Chamoun, S. Choquet, Eileen M. Boyle, C. Houillier +7 more
2017Neurology68 citations
Semantic Scholar
Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents
Sangmin Lee, Sanjay R. Mohan, Jessica Knupp, K. Chamoun +7 more
2022Journal of Hematology & Oncology31 citations Open access
Semantic Scholar
Socioeconomic Factors and Survival of Multiple Myeloma Patients
K. Chamoun, Amin Firoozmand, P. Caimi, P. Fu +8 more
2021Cancers30 citations Open access
Semantic Scholar
Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia
K. Chamoun, H. Kantarjian, Xue-Mei Wang, K. Naqvi +12 more
2019Cancer24 citations Open access
Semantic Scholar
Selinexor Plus Ruxolitinib in JAK Inhibitor (JAKi)-Naïve Patients with Myelofibrosis: Long Term Follow up from XPORT-MF-034 Suggestive of Disease Modification
S. Tantravahi, A. Kishtagari, K. Maher, S. Mohan +6 more
2023Blood18 citations
Semantic Scholar
Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study
M. Maerevoet, J. Zijlstra, G. Follows, R. Casasnovas +30 more
2021Journal of Hematology & Oncology15 citations Open access
Semantic Scholar
Early detection of transformation to BPDCN in a patient with MDS
K. Chamoun, S. Loghavi, N. Pemmaraju, M. Konopleva +9 more
2018Experimental Hematology & Oncology15 citations Open access
Semantic Scholar
Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 years
Q. Bashir, K. Chamoun, D. Milton, Maliha Khan +15 more
2019Leukemia and Lymphoma13 citations
Semantic Scholar
A Phase 2 Study to Evaluate the Efficacy and Safety of Selinexor in Patients with Myelofibrosis Refractory or Intolerant to JAK Inhibitors
S. Tantravahi, S. Kim, Divya Sundar, Ami B. Patel +8 more
2021Blood12 citations Open access
Semantic Scholar
Association of bone marrow fibrosis with inferior survival outcomes in chronic myelomonocytic leukemia
Maliha Khan, T. Muzzafar, H. Kantarjian, Ifra Badar +12 more
2018Annals of Hematology11 citations Open access
Semantic Scholar
Investigational CHK1 inhibitors in early stage clinical trials for acute myeloid leukemia
K. Chamoun, G. Borthakur
2018Expert Opinion on Investigational Drugs9 citations
Semantic Scholar
A Phase I/II Study of AZD0305, a Novel Antibody-Drug Conjugate (ADC) Targeting GPRC5D, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Sueh-Li Lim, B. Augustson, H. Mian, E. Stadtmauer +8 more
2024Blood8 citations
Semantic Scholar
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.
R. Casasnovas, G. Follows, J. Zijlstra, J. Vermaat +29 more
2021Clinical Lymphoma, Myeloma & Leukemia8 citations Open access
Semantic Scholar
Refractory inflammatory myopathy in hematopoietic stem cell transplant patients with chronic graft-versus-host disease: report of two cases
Sophia B. Golec, E. Rabinovich, M. Cohen, Linda K. Baer +2 more
2019Hematology, Transfusion and Cell Therapy8 citations Open access
Semantic Scholar
A case of neurocognitive deficit strongly related to dasatinib therapy
K. Chamoun, E. Rabinovich, Linda K. Baer, P. Fastenau +1 more
2019Hematology, Transfusion and Cell Therapy8 citations Open access
Semantic Scholar
Allogeneic Transplantation after Myeloablative Rituximab/BEAM +/− Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-up Results
K. Chamoun, D. Milton, C. Ledesma, K. Young +14 more
2019Biology of Blood and Marrow Transplantation7 citations Open access
Semantic Scholar
Nonbacterial Thrombotic Endocarditis
N. Parker, Rami Atallah, Nicholas Ojile, K. Chamoun +2 more
2020Kansas journal of medicine6 citations Open access
Semantic Scholar
CPX-351 for the Treatment of High-Risk Patients with Acute Myeloid Leukemia
R. Assi, H. Kantarjian, S. Verstovsek, G. Garcia-Manero +11 more
20166 citations
Semantic Scholar
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study.
Michaela Schuster, J. Zijlstra, R. Casasnovas, J. Vermaat +30 more
2021Clinical Lymphoma, Myeloma & Leukemia5 citations Open access
Semantic Scholar
The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study
J. Zijlstra, G. Follows, R. Casasnovas, J. Vermaat +26 more
2022Cancers4 citations Open access
Semantic Scholar
P1005: A PHASE 1, OPEN-LABEL, DOSE-ESCALATION STUDY OF SELINEXOR PLUS RUXOLITINIB IN PATIENTS WITH TREATMENT-NAÏVE MYELOFIBROSIS
H. Ali, A. Kishtagari, K. Maher, S. Mohan +9 more
2022HemaSphere4 citations Open access
Semantic Scholar
Updated overall survival of eltanexor for the treatment of patients with hypomethylating agent refractory myelodysplastic syndrome.
Sangmin Lee, Sanjay R. Mohan, Jessica Knupp, K. Chamoun +6 more
20214 citations
Semantic Scholar
Demographic characteristics of smoldering multiple myeloma patients: A hospital-based study including 11,643 patients.
K. Chamoun, R. Kyasaram, L. Metheny, M. Gallogly +4 more
2019Journal of Clinical Oncology4 citations
Semantic Scholar
Insurance status and survival of multiple myeloma (MM) patients.
K. Chamoun, M. D. de Lima, P. Caimi, P. Fu +8 more
2019Journal of Clinical Oncology4 citations
Semantic Scholar
A Global, Phase 3, Randomized, Double-Blind Study to Evaluate Safety and Efficacy of Selinexor, an XPO-1 Inhibitor, in Combination with Ruxolitinib in JAK Inhibitor-Naïve Myelofibrosis (XPORT-MF-034)
K. Maher, R. Rampal, P. Bose, N. Podoltsev +5 more
2023Blood3 citations Open access
Semantic Scholar
Abstract CT261: A Phase 1, open-label, dose-escalation study of selinexor plus ruxolitinib in patients with treatment-naïve myelofibrosis
H. Ali, A. Kishtagari, K. Maher, Sanjay R. Mohan +5 more
2023Cancer Research3 citations
Semantic Scholar
Selinexor (SEL) plus ruxolitinib (RUX) in JAK inhibitor (JAKi) treatment-naïve patients with myelofibrosis: Updated results from XPORT-MF-034.
H. Ali, A. Kishtagari, K. Maher, Sanjay R. Mohan +4 more
2023Journal of Clinical Oncology3 citations
Semantic Scholar
A Phase 1, Open-Label, Dose-Escalation Study of Selinexor Plus Ruxolitinib in Patients with Treatment-Naïve Myelofibrosis
H. Ali, A. Kishtagari, K. Maher, Sanjay R. Mohan +5 more
2022Blood3 citations
Semantic Scholar
Impact of next-generation sequencing (NGS) on treatment selection in acute myeloid leukemia (AML).
R. Assi, A. Piérola, Devendra Kc, Yasmin M. Abaza +16 more
20183 citations
Semantic Scholar
CML Patients Outcome after TKI Discontinuation: A Single Institution Experience in the US
K. Chamoun, H. Kantarjian, M. Rios, R. Assi +11 more
20163 citations
Semantic Scholar
Selinexor Efficacy and Safety Are Independent of Renal Function in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis from the Pivotal Phase 2b Sadal Study
M. Schuster, M. Canales, J. Westin, J. Zijlstra +34 more
20202 citations Open access
Semantic Scholar
Stem Cell Transplant Minimizes Insurance Coverage-Driven Outcomes Disparities for Multiple Myeloma Patients
Gayathri Ravi, K. Chamoun, K. Boughan, S. Cao +3 more
2019Blood2 citations Open access
Semantic Scholar
POSTER: MPN-336 Selinexor Plus Ruxolitinib in JAK Inhibitor (JAKi) Treatment-Naïve Patients With Myelofibrosis: Updated Results and Subgroup Analyses from XPORT-MF-034
Haris Ali, A. Kishtagari, K. Maher, Sanjay R. Mohan +4 more
2023Clinical Lymphoma, Myeloma & Leukemia1 citations Open access
Semantic Scholar
Impact of Regional Income and Insurance Status on Survival of Multiple Myeloma Patients: Autologous Stem Cell Transplant as an Equalizer
K. Chamoun, M. D. de Lima, P. Fu, P. Caimi +6 more
2019Clinical Lymphoma, Myeloma & Leukemia1 citations
Semantic Scholar
Risk of Progression in Patients with Smoldering Myeloma
F. Covut, K. Chamoun, L. Metheny, K. Boughan +3 more
2019Blood1 citations Open access
Semantic Scholar
Comparable survival of African-Americans and Caucasian patients with multiple myeloma: A hospital-based study including 117,926 patients.
E. Malek, K. Chamoun, P. Caimi, S. Gerson +4 more
2019Journal of Clinical Oncology1 citations
Semantic Scholar
Phase 1 trial of anti-CD19 chimeric antigen receptor T (CAR-T) cells with tumor necrosis alfa receptor superfamily 19 (TNFRSF19) transmembrane domain.
P. Caimi, J. Reese, F. Otegbeye, D. Schneider +16 more
2019Journal of Clinical Oncology1 citations
Semantic Scholar
The Impact of Clonal Hematopoiesis of Indeterminate Potential on Survival in Patients with Newly Diagnosed Acute Myeloid Leukemia
K. Sasaki, R. Kanagal-Shamanna, G. Montalban-Bravo, R. Assi +19 more
2018Blood1 citations Open access
Semantic Scholar
Weight Increase during Induction Therapy Predicts Intensive Care Unit (ICU) Transfer in Patients (Pts) with Acute Promyelocytic Leukemia (APL)
K. Chamoun, H. Kantarjian, K. Naqvi, Xue-Mei Wang +11 more
2018Blood1 citations
Semantic Scholar
P1020: SELINEXOR (SEL) PLUS RUXOLITINIB (RUX) IN JAK INHIBITOR (JAKI) TREATMENT-NAÏVE PATIENTS WITH MYELOFIBROSIS: UPDATED RESULTS FROM XPORT-MF-034
H. Ali, A. Kishtagari, K. Maher, Sanjay R. Mohan +4 more
2023HemaSphere0 citations Open access
Semantic Scholar
Updated Efficacy of Eltanexor Monotherapy in Patients with Higher Risk Hypomethylating Myelodysplastic Syndrome Primary Refractory to Hypomethylating Agents
Sangmin Lee, Sanjay R. Mohan, Jessica Knupp, K. Chamoun +8 more
2021Blood0 citations Open access
Semantic Scholar
Effect of Age on the Efficacy and Safety of Single Agent Oral Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Pivotal Study
M. Schuster, M. Canales, J. Westin, J. Zijlstra +34 more
2020Blood0 citations
Semantic Scholar
Oral Vs Intravenous Tacrolimus Post Allogeneic Stem Cell Transplant: A Retrospective Analysis
K. Chamoun, T. Getz, Merle Kolk, M. D. De Lima +11 more
2019Biology of Blood and Marrow Transplantation0 citations Open access
Semantic Scholar
The Prognostic Factors for Early Fatal Outcome in Patients with Multiple Myeloma
Sowjanya Vuyyala, K. Chamoun, P. Fu, S. Cao +3 more
2019Blood0 citations Open access
Semantic Scholar
PHASE 1 STUDY OF ANTICD19 CAR‐T CELLS WITH TNFα TRANSMEMBRANE DOMAIN AND 41BB, CD3ζ COSTIMULATORY DOMAINS. RESPONSES IN SUBJECTS WITH RAPIDLY PROGRESSIVE LYMPHOMA
P. Caimi, J. Reese-Koc, F. Otegbeye, D. Schneider +16 more
2019Hematological Oncology0 citations
Semantic Scholar
Peri-Transplant Venous Thromboembolism in Patients with Multiple Myeloma
K. Chamoun, F. Covut, M. Park, P. Caimi +7 more
2019Biology of Blood and Marrow Transplantation0 citations Open access
Semantic Scholar
Impact of Next-Generation Sequencing on Treatment Choices for Patients with Acute Myeloid Leukemia
A. Piérola, R. Assi, Devendra Kc, Yasmin M. Abaza +19 more
20170 citations
Semantic Scholar
Bortezomib, rituximab, and risk of graft-versus-host disease (GVHD) after BEAM conditioning for allogeneic stem cell transplantation (alloSCT).
K. Chamoun, A. Gulbis, D. Milton, E. Jabbour +2 more
20170 citations
Semantic Scholar
Immune-related gene expression deficit of leukemia stem cells (LSC) in AML.
K. Chamoun, C. Benton, A. Alrawi, R. Jacamo +8 more
20170 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Caimi×15
Invite
P. Caimi — researcher profile on SciRah
E. Malek×11
Invite
E. Malek — researcher profile on SciRah
H. Kantarjian×10
Invite
H. Kantarjian — researcher profile on SciRah
G. Garcia-Manero×10
Invite
G. Garcia-Manero — researcher profile on SciRah

×10

Invite

C. Dinardo — researcher profile on SciRah

Invite

E. Jabbour — researcher profile on SciRah

M. D. de Lima×10

Invite

M. D. de Lima — researcher profile on SciRah

G. Borthakur×9

Invite

G. Borthakur — researcher profile on SciRah

Invite

T. Kadia — researcher profile on SciRah

Invite

J. Cortes — researcher profile on SciRah

Invite

F. Ravandi — researcher profile on SciRah

Invite

N. Daver — researcher profile on SciRah